196 related articles for article (PubMed ID: 32987383)
1. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
Al-Awadhi A; Adekile A; Marouf R
Acta Haematol; 2021; 144(2):182-189. PubMed ID: 32987383
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
Al-Awadhi A; Adekile A; Marouf R
J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
[TBL] [Abstract][Full Text] [Related]
3. Evaluating von Willebrand factor and ADAMTS13 levels in thalassemia major patients and assessing a possible association with Thrombospondin-1.
Al-Sabaan K; Al-Awadhi A
Int J Lab Hematol; 2023 Dec; 45(6):945-952. PubMed ID: 37438087
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
5. Determination of vWF, ADAMTS-13 and Thrombospondin-1 in Venous Thromboembolism and Relating Them to the Presence of Factor V Leiden Mutation.
Al-Awadhi A; Marouf R; Jadaon MM; Al-Awadhy MM
Clin Appl Thromb Hemost; 2024; 30():10760296231223195. PubMed ID: 38225166
[TBL] [Abstract][Full Text] [Related]
6. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions.
Barabino GA; Wise RJ; Woodbury VA; Zhang B; Bridges KA; Hebbel RP; Lawler J; Ewenstein BM
Blood; 1997 Apr; 89(7):2560-7. PubMed ID: 9116303
[TBL] [Abstract][Full Text] [Related]
8. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.
Chen J; Hobbs WE; Le J; Lenting PJ; de Groot PG; López JA
Blood; 2011 Mar; 117(13):3680-3. PubMed ID: 21300978
[TBL] [Abstract][Full Text] [Related]
9. ADAMTS-13-VWF axis in sickle cell disease patients.
Ladeira VS; Barbosa AR; Oliveira MM; Ferreira LGR; de Oliveira Júnior WV; de Oliveira Renó C; Reis EA; Chaves DG; Dusse LMS; Dos Santos HL; de Barros Pinheiro M; Rios DRA
Ann Hematol; 2021 Feb; 100(2):375-382. PubMed ID: 33404693
[TBL] [Abstract][Full Text] [Related]
10. Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice.
Pimanda JE; Ganderton T; Maekawa A; Yap CL; Lawler J; Kershaw G; Chesterman CN; Hogg PJ
J Biol Chem; 2004 May; 279(20):21439-48. PubMed ID: 14981081
[TBL] [Abstract][Full Text] [Related]
11. Control of von Willebrand factor multimer size by thrombospondin-1.
Xie L; Chesterman CN; Hogg PJ
J Exp Med; 2001 Jun; 193(12):1341-9. PubMed ID: 11413189
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
[TBL] [Abstract][Full Text] [Related]
13. Contribution of ADAMTS13-independent VWF regulation in sickle cell disease.
Hunt RC; Katneni U; Yalamanoglu A; Indig FE; Ibla JC; Kimchi-Sarfaty C
J Thromb Haemost; 2022 Sep; 20(9):2098-2108. PubMed ID: 35753044
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
[TBL] [Abstract][Full Text] [Related]
15. Smoking, von Willebrand factor and ADAMTS-13 in healthy males.
Al-Awadhi AM; Jadaon MM; Alsayegh FA; Al-Sharrah SK
Scand J Clin Lab Invest; 2012 Dec; 72(8):614-8. PubMed ID: 23020229
[TBL] [Abstract][Full Text] [Related]
16. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
Edvardsen MS; Hansen ES; Ueland T; Aukrust P; Brækkan SK; Morelli VM; Hansen JB
J Thromb Haemost; 2023 May; 21(5):1227-1237. PubMed ID: 36736832
[TBL] [Abstract][Full Text] [Related]
17. Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage.
Wan H; Wang Y; Ai J; Brathwaite S; Ni H; Macdonald RL; Hol EM; Meijers JCM; Vergouwen MDI
J Thromb Haemost; 2018 Jul; 16(7):1413-1422. PubMed ID: 29729651
[TBL] [Abstract][Full Text] [Related]
18. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.
Karakaya B; Tombak A; Serin MS; Tiftik N
Hematology; 2016 Jun; 21(5):295-9. PubMed ID: 26872106
[TBL] [Abstract][Full Text] [Related]
19. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
Islek A; Ilhan D; Ozturk N; Guven B; Sag E
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e951-e956. PubMed ID: 33369998
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
